Conference Vetting System

Pharma Events

MedTech Europe Conference Vetting System and EFPIA e4ethics join forces. In the context of their respective broad ethical programs, MedTech Europe’s Conference Vetting System (CVS) and EFPIA’s e4ethics assessment platform are coming together. EFPIA is the European Federation of Pharmaceutical Industries and Associations.

Since 1st January 2021, the two trade associations, MedTech Europe and EFPIA, have a unique and common platform assessing medical conferences.

MedTech Europe, the trade association representing the medical technologies industry in Europe, and EFPIA, the European Federation of Pharmaceutical Industries and Associations, have a long-standing experience and commitment to strong ethical principles for the support provided in the context of medical congresses (i.e. Third-Party Organised Educational Events).

A new approach to assessment of Third-Party Educational Events

In the context of their broad ethical programmes, both associations have decided to combine the assessments done by MedTech Europe’s Conference Vetting System (CVS) and EFPIA’s platform (e4ethics). Building on existing capacities to create efficiency, the objective of such a move is to ensure consistency and harmonisation across the healthcare industry, for the benefit of all stakeholders involved.

Launched respectively in 2012 and 2010, both online systems review, assess and approve Third-Party Organised Educational Events (i.e. congresses) in accordance with their corresponding Codes of Ethical Business Practice. Therefore, a substantial number of conferences are currently being assessed by both systems.

Essence of the change

Since 1st January 2021, with a 6-month pilot period, both platforms are aligned in most aspects:

  • Both platforms operate independently from EFPIA and MedTech Europe, via a common Compliance team, to ensure objectivity and independence in conference assessments.
  • e4ethics is aligned with the CVS criteria and approach, including the online proactive submissions by companies or congress organisers (Professional Congress Organisers as well as scientific societies).
  • The submission procedure and appeal process is identical for both systems.

The type of Events qualifying for review will remain different:

  • For Events assessed under e4ethics, only those that qualify as major international Events taking place in the countries within the scope of the EFPIA Code, will be reviewed. Events in which Healthcare Professionals coming from more than 5 countries may take part and which are expected to attract a significant number of participants (at least 500), will be looked at
  • On the other hand, within the CVS, international Events need to be reviewed when they are taking place within the MedTech Europe geographical scope. This includes:
    • Events attended by delegates coming from at least two countries of MedTech Europe geographical scope; and
    • Events taking place outside the MedTech Europe geographic area, attended by delegates who are HCPs registered and practicing in the MedTech geographical area.

Assessment outcomes are binding for all member companies as of 1st January 2021, whether EFPIA and/or MedTech Europe. As it is already the case for MedTech Europe members, all companies need to receive a positive assessment, to support an Event.

What and how it is supported by EFPIA & MedTech Europe members, remains unchanged

The type of support remains regulated under the respective EFPIA and MedTech Europe Codes. As such, what and how EFPIA member companies can support Events and Healthcare Professionals, will differ from MedTech Europe member companies. The latter can never sponsor Healthcare Professionals directly. EFPIA member companies, conversely, can financially support the cost of travelling, registration, and lodging of individual Healthcare Professionals to attend European third-party conferences in accordance with the EFPIA Code – and from 1 January 2021 onwards, as long as the Event has been vetted as compliant.

Both industries have invested in the implementation of self-regulating initiatives, in particular with regards to their interaction with Healthcare Professionals and Healthcare Organisations. This move further supports and facilitates their commitment to safeguard these interactions, and preserve the ethical business conduct of the entire healthcare sector, as well as the ability to continue to collaborate with the healthcare community.

For more information, please visit www.ethicalmedtech.eu & www.e4ethics.org.

For questions, you may contact: clarisse.aillet@ethicalmedtech.eu.

About EFPIA

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop, and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy. 

For more information, visit www.efpia.eu

About MedTech Europe

MedTech Europe is the European trade association representing the medical technology industry including diagnostics, medical devices and digital health. Our members are national, European, and multinational companies, as well as a network of national medical technology associations who research, develop, manufacture, distribute and supply health-related technologies, services and solutions.

For more information, visit www.medtecheurope.org